Publication: The Utility of CRISPR/Cas9 Technology to Attenuate Apoptotic Pressure in Monoclonal Antibody (mAb) Producing Cells
Program
Authors
Doymaz M. Z.
Aydın B. N.
Çetin N. S.
Kaygusuz A.
Advisor
Date
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Description
Source:
Keywords:
Keywords
Citation
Doymaz M. Z., Aydın B. N., Çetin N. S., Kaygusuz A., \"The Utility of CRISPR/Cas9 Technology to Attenuate Apoptotic Pressure in Monoclonal Antibody (mAb) Producing Cells\", 5th International Molecular Immunology & Immunogenetics Congress (MIMIC-V) Scientific Programme, İzmir, Türkiye, 20 - 22 Ekim 2022, ss.38